Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Pancreas”

1,537 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,537 results

Early research (Phase 1)Ended earlyNCT04807972
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Who this might be right for
Pancreatic Cancer
AbbVie 40
Not applicableStudy completedNCT05884463
What this trial is testing

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Who this might be right for
18F-FAPI18F-FDGPancreas Adenocarcinoma+2 more
Zhejiang University 62
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Early research (Phase 1)Study completedNCT05383352
What this trial is testing

Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Ipsen 177
Not applicableStudy completedNCT02072616
What this trial is testing

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Who this might be right for
Circulating Tumor CellsPancreatic AdenocarcinomaCirculating Tumor DNA (KRAS)+1 more
University Hospital, Rouen 101
Not applicableStudy completedNCT01765036
What this trial is testing

Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Société Française d'Endoscopie Digestive 100
Testing effectiveness (Phase 2)Study completedNCT02243371
What this trial is testing

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Who this might be right for
Previously Treated Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 93
Early research (Phase 1)UnknownNCT03703063
What this trial is testing

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 30
Not applicableLooking for participantsNCT04037007
What this trial is testing

Efficacy of Fistulotomy for Biliary Cannulation

Who this might be right for
CholangiocarcinomaCholedocholithiasis; CholangitisPancreatic Cancer+1 more
Coordinación de Investigación en Salud, Mexico 320
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Not applicableUnknownNCT02079363
What this trial is testing

DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer

Who this might be right for
Pancreatic DiseasesPancreatic NeoplasmsPancreatitis
Aalborg University Hospital 330
Not applicableEnded earlyNCT01071434
What this trial is testing

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Who this might be right for
Pancreatic CancerLiver CancerLung Cancer+7 more
Stanford University 5
Not applicableStudy completedNCT04406571
What this trial is testing

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHU de Reims 700
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Early research (Phase 1)Looking for participantsNCT06756035
What this trial is testing

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who this might be right for
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Context Therapeutics Inc. 70
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Load More Results